Movano (NASDAQ:MOVE) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?

Movano Inc. (NASDAQ:MOVEGet Free Report) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.51 and traded as high as $8.21. Movano shares last traded at $7.97, with a volume of 18,140 shares.

More Movano News

Here are the key news stories impacting Movano this week:

  • Positive Sentiment: Q3 earnings beat on EPS: Movano reported ($4.73) EPS vs. consensus ($7.00) — the narrower loss on a per‑share basis is a positive datapoint that can limit downside if management can show improving unit economics and execution.
  • Neutral Sentiment: Geopolitical risk and international diplomacy may pressure small‑cap tech sentiment today; high‑profile Asia diplomacy (China, Thailand, Cambodia) is in the headlines and can drive risk‑off flows. Thailand accuses Cambodia of breaking newly signed ceasefire – BBC
  • Neutral Sentiment: Macro/market headlines around crypto regulation and tech/AI momentum could reallocate investor risk appetite between growth and speculative small caps. These themes are being actively discussed in the newsflow today. Trump Ready to Sign Crypto Legislation — Blockonomi
  • Negative Sentiment: Revenue shortfall and poor profitability: Q3 revenue was only $0.08M vs. analyst estimates ~$3.9M and margins/ROE are deeply negative — fundamentals leave little room for valuation support absent a clear revenue turnaround.
  • Negative Sentiment: Very small market cap and thin liquidity amplify price moves: market cap ~$6.6M and today’s volume (~18k vs. avg ~295k) mean limited buyers/sellers can move the stock sharply on modest flows or negative headlines.
  • Negative Sentiment: Technical pressure: price sits below the 50‑day moving average (~$8.56) (though above the 200‑day ~ $7.50), which can trigger short‑term selling from trend‑sensitive traders.

Analysts Set New Price Targets

Several research firms have recently weighed in on MOVE. Wall Street Zen raised shares of Movano to a “hold” rating in a research note on Saturday, December 20th. Weiss Ratings reissued a “sell (e+)” rating on shares of Movano in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.

View Our Latest Stock Analysis on MOVE

Movano Price Performance

The stock’s fifty day moving average is $8.57 and its 200-day moving average is $7.51. The stock has a market cap of $6.62 million, a PE ratio of -0.74 and a beta of 0.76.

Movano (NASDAQ:MOVEGet Free Report) last issued its earnings results on Friday, November 14th. The technology company reported ($4.73) EPS for the quarter, topping analysts’ consensus estimates of ($7.00) by $2.27. The company had revenue of $0.08 million for the quarter, compared to the consensus estimate of $3.88 million. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%.

Institutional Investors Weigh In On Movano

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC bought a new stake in Movano Inc. (NASDAQ:MOVEFree Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano as of its most recent SEC filing. Institutional investors own 16.64% of the company’s stock.

About Movano

(Get Free Report)

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.

Featured Articles

Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.